Beam Therapeutics Inc.
Biotechnology company · Cambridge, Massachusetts, United States · Nasdaq: BEAM
Beam Therapeutics Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker BEAM. It has reported private securities offerings to the US SEC, most recently $84 million sold in a notice filed in 2019.
Beam Therapeutics at a glance
What does Beam Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $83.6 million sold (2019).
Frequently asked questions about Beam Therapeutics
Where is Beam Therapeutics headquartered?
Beam Therapeutics Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Beam Therapeutics do?
Beam Therapeutics Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Beam Therapeutics a public company?
Yes. Beam Therapeutics Inc. trades on Nasdaq under the ticker BEAM.
When was Beam Therapeutics founded?
The earliest incorporation on record for Beam Therapeutics Inc. is in 2017, according to public company registers.
Similar companies
- Editas Medicine, Inc.Cambridge, Massachusetts, United States
- Moderna, Inc.Cambridge, Massachusetts, United States
- Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
- Epicore Biosystems, Inc.Cambridge, Massachusetts, United States
- Genzyme CorpCambridge, Massachusetts, United States
- Neutrolis Inc.Cambridge, Massachusetts, United States
- Biogen Inc.Cambridge, Massachusetts, United States
- Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.